RU96119957A - PHARMACEUTICAL COMBINED DRUG FOR HORMONAL CONTRACEPTION - Google Patents
PHARMACEUTICAL COMBINED DRUG FOR HORMONAL CONTRACEPTIONInfo
- Publication number
- RU96119957A RU96119957A RU96119957/14A RU96119957A RU96119957A RU 96119957 A RU96119957 A RU 96119957A RU 96119957/14 A RU96119957/14 A RU 96119957/14A RU 96119957 A RU96119957 A RU 96119957A RU 96119957 A RU96119957 A RU 96119957A
- Authority
- RU
- Russia
- Prior art keywords
- hormonal
- estradiol
- estrogen
- component
- preparation according
- Prior art date
Links
- 230000003054 hormonal effect Effects 0.000 title claims 15
- 229940079593 drug Drugs 0.000 title claims 2
- 239000003814 drug Substances 0.000 title claims 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 10
- 229940011871 estrogen Drugs 0.000 claims 6
- 239000000262 estrogen Substances 0.000 claims 6
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 claims 5
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims 5
- 229960005309 estradiol Drugs 0.000 claims 5
- 229960002568 ethinylestradiol Drugs 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 3
- 229960004766 estradiol valerate Drugs 0.000 claims 3
- 239000000583 progesterone congener Substances 0.000 claims 3
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 claims 2
- 229940088623 biologically active substance Drugs 0.000 claims 2
- 229960000978 cyproterone acetate Drugs 0.000 claims 2
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims 2
- 229960004976 desogestrel Drugs 0.000 claims 2
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 claims 2
- GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 claims 2
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 claims 2
- 229960005352 gestodene Drugs 0.000 claims 2
- 229960004400 levonorgestrel Drugs 0.000 claims 2
- 229940053934 norethindrone Drugs 0.000 claims 2
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 claims 2
- 229960000417 norgestimate Drugs 0.000 claims 2
- KIQQMECNKUGGKA-NMYWJIRASA-N norgestimate Chemical compound O/N=C/1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(OC(C)=O)C#C)[C@@H]4[C@@H]3CCC2=C\1 KIQQMECNKUGGKA-NMYWJIRASA-N 0.000 claims 2
- 238000004806 packaging method and process Methods 0.000 claims 2
- 230000000035 biogenic effect Effects 0.000 claims 1
- -1 drospironenone Chemical compound 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 230000016087 ovulation Effects 0.000 claims 1
- 229940070710 valerate Drugs 0.000 claims 1
Claims (6)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4411585A DE4411585A1 (en) | 1994-03-30 | 1994-03-30 | Combined pharmaceutical preparation for hormonal contraception |
| DEP4411585.7 | 1994-03-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU96119957A true RU96119957A (en) | 1999-01-20 |
| RU2165258C2 RU2165258C2 (en) | 2001-04-20 |
Family
ID=6514578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU96119957/14A RU2165258C2 (en) | 1994-03-30 | 1995-03-30 | Pharmaceutical combined preparation for hormonal contraception |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5756490A (en) |
| EP (1) | EP0750501B1 (en) |
| JP (1) | JPH09511243A (en) |
| KR (1) | KR100352571B1 (en) |
| CN (1) | CN1108800C (en) |
| AT (1) | ATE222494T1 (en) |
| AU (1) | AU2073595A (en) |
| BG (1) | BG63192B1 (en) |
| BR (1) | BR9507251A (en) |
| CA (1) | CA2186739A1 (en) |
| CZ (1) | CZ291698B6 (en) |
| DE (2) | DE4411585A1 (en) |
| DK (1) | DK0750501T3 (en) |
| ES (1) | ES2181770T3 (en) |
| FI (1) | FI963831A7 (en) |
| HU (1) | HUT75521A (en) |
| NO (1) | NO964089L (en) |
| NZ (1) | NZ282824A (en) |
| PL (1) | PL316569A1 (en) |
| PT (1) | PT750501E (en) |
| RO (1) | RO118375B1 (en) |
| RU (1) | RU2165258C2 (en) |
| SK (1) | SK124396A3 (en) |
| UA (1) | UA41401C2 (en) |
| WO (1) | WO1995026730A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407082B1 (en) | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
| DE4344462C2 (en) | 1993-12-22 | 1996-02-01 | Schering Ag | Composition for contraception |
| DK0792152T3 (en) * | 1994-11-22 | 2004-07-12 | Balance Pharmaceuticals Inc | Procedures for Pregnancy Prevention |
| DE19513662A1 (en) * | 1995-04-08 | 1996-10-10 | Schering Ag | Combined pharmaceutical preparation for hormonal contraception |
| DE19525017A1 (en) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmaceutical combination preparation, kit and method for hormonal contraception |
| AU726283B2 (en) * | 1995-06-28 | 2000-11-02 | Schering Aktiengesellschaft | Pharmaceutical combined preparations, kit and method for hormonal contraception |
| AU2815897A (en) * | 1996-05-08 | 1997-11-26 | American Home Products Corporation | Oral contraceptive |
| US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
| NZ333862A (en) * | 1996-07-26 | 2000-08-25 | American Home Prod | Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen |
| US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
| DE69729956T2 (en) * | 1996-07-26 | 2004-12-16 | Wyeth | ORAL, ONE-STEP CONCEPT PREVENTION METHOD AND COMBINATION PRODUCT CONTAINING THE STAGE AND ESTROGEN |
| US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
| AU3888697A (en) * | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
| US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
| US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
| US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
| US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| EP2305267A3 (en) | 1999-08-31 | 2011-08-17 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| HRP20020258B1 (en) * | 1999-08-31 | 2007-05-31 | Schering Aktiengesellschaft | PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS CONTRACEPTIVE |
| US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| SI1214076T1 (en) * | 1999-08-31 | 2004-06-30 | Schering Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| SI1453521T1 (en) * | 2001-12-05 | 2013-11-29 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| CA2771944A1 (en) * | 2003-07-16 | 2005-01-27 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| KR20060129175A (en) * | 2003-10-01 | 2006-12-15 | 얀센 파마슈티카 엔.브이. | Extended Phase 3 Contraception |
| US20050113350A1 (en) * | 2003-11-26 | 2005-05-26 | Bernd Duesterberg | Extended use combination comprising estrogens and progestins |
| EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
| US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| US7704984B2 (en) | 2005-04-22 | 2010-04-27 | Warner Chilcott Company, Llc | Extended estrogen dosing contraceptive regimen |
| WO2007106264A2 (en) * | 2006-03-02 | 2007-09-20 | Warner Chilcott Company, Inc. | Extended cycle multiphasic oral contraceptive method |
| US11376263B2 (en) | 2020-10-08 | 2022-07-05 | Fortress Biotech, Inc. | Cyproterone acetate compositions and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6615481A (en) * | 1966-11-02 | 1968-05-03 | ||
| US3639600A (en) * | 1969-08-28 | 1972-02-01 | Upjohn Co | Process of establishing cyclicity in a human female |
| US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
| DK174724B1 (en) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Use of a composition comprising an estrogen and a progestogen for the preparation of a dosage form to provide hormone replacement therapy and contraception for women during the premenopause and pack to provide the composition |
| RU2043105C1 (en) * | 1987-11-04 | 1995-09-10 | Центр по химии лекарственных средств | Contraceptive agent |
| IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| DE4104385C1 (en) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich |
-
1994
- 1994-03-30 DE DE4411585A patent/DE4411585A1/en not_active Withdrawn
-
1995
- 1995-03-30 AT AT95913171T patent/ATE222494T1/en not_active IP Right Cessation
- 1995-03-30 CN CN95193056A patent/CN1108800C/en not_active Expired - Fee Related
- 1995-03-30 WO PCT/EP1995/001190 patent/WO1995026730A1/en not_active Ceased
- 1995-03-30 UA UA96104081A patent/UA41401C2/en unknown
- 1995-03-30 NZ NZ282824A patent/NZ282824A/en unknown
- 1995-03-30 SK SK1243-96A patent/SK124396A3/en unknown
- 1995-03-30 EP EP95913171A patent/EP0750501B1/en not_active Expired - Lifetime
- 1995-03-30 RU RU96119957/14A patent/RU2165258C2/en not_active IP Right Cessation
- 1995-03-30 DE DE59510333T patent/DE59510333D1/en not_active Expired - Fee Related
- 1995-03-30 KR KR1019960705421A patent/KR100352571B1/en not_active Expired - Fee Related
- 1995-03-30 RO RO96-01897A patent/RO118375B1/en unknown
- 1995-03-30 DK DK95913171T patent/DK0750501T3/en active
- 1995-03-30 AU AU20735/95A patent/AU2073595A/en not_active Abandoned
- 1995-03-30 JP JP7525409A patent/JPH09511243A/en not_active Ceased
- 1995-03-30 ES ES95913171T patent/ES2181770T3/en not_active Expired - Lifetime
- 1995-03-30 PL PL95316569A patent/PL316569A1/en unknown
- 1995-03-30 CA CA002186739A patent/CA2186739A1/en not_active Abandoned
- 1995-03-30 HU HU9602657A patent/HUT75521A/en unknown
- 1995-03-30 CZ CZ19962879A patent/CZ291698B6/en not_active IP Right Cessation
- 1995-03-30 US US08/718,401 patent/US5756490A/en not_active Expired - Fee Related
- 1995-03-30 BR BR9507251A patent/BR9507251A/en not_active Application Discontinuation
- 1995-03-30 PT PT95913171T patent/PT750501E/en unknown
-
1996
- 1996-09-25 FI FI963831A patent/FI963831A7/en not_active Application Discontinuation
- 1996-09-27 NO NO964089A patent/NO964089L/en unknown
- 1996-10-28 BG BG100940A patent/BG63192B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU96119957A (en) | PHARMACEUTICAL COMBINED DRUG FOR HORMONAL CONTRACEPTION | |
| RU96115196A (en) | COMPOSITION FOR CONTRACEPTION | |
| US9132137B2 (en) | Graduated estrogen contraceptive | |
| CA2640520C (en) | Extended cycle multiphasic oral contraceptive method | |
| CN1137690C (en) | Pharmaceutical combination, kit and method for hormonal contraception | |
| RU2122854C1 (en) | Combined preparation for contraception, pharmaceutical container for contraception | |
| RU2165258C2 (en) | Pharmaceutical combined preparation for hormonal contraception | |
| RU2189819C2 (en) | Schemes for progestogen - antiprogestogen intake | |
| EP1898953B1 (en) | Quadraphasic continuous graduated estrogen contraceptive | |
| JP2004508398A5 (en) | ||
| CA2420292A1 (en) | Contraception process and administration form for the same | |
| RU2001129160A (en) | Intermittent hormone replacement therapy with low doses of estrogen | |
| KR970704450A (en) | Use of a progesterone antagonist and gestagen to treat endometrial hyperplasia or uterine leiomyoma (Use of a Progesterone Antagonist and a Gestagen for Endometriosis or Leiomyomate Uteri) | |
| RU97118464A (en) | PHARMACEUTICAL COMBINED DRUG FOR HORMONAL CONTRACEPTION | |
| US7935691B2 (en) | Extended cycle multiphasic oral contraceptive kit | |
| NZ307178A (en) | Medicament for contraception; contains two, separately packed, sequential hormonal components | |
| CA2605299C (en) | Extended estrogen dosing contraceptive regimen | |
| RU2000115313A (en) | GESTAGEN-ANTI-GESTAGEN RECEPTION DIAGRAMS | |
| WO1994004156A1 (en) | Antiprogestogen containing contraceptives | |
| MXPA01010976A (en) | Use of antiprogestagens in combined therapy. | |
| MXPA98010747A (en) | Regimes of progestogeno-anti-progestog | |
| RU97103327A (en) | APPLICATION OF A COMBINED PRODUCT CONTAINING A COMPETING PROGESTERON AND HESTAGEN ANTAGONIST TO PRODUCE A MEDICINE FOR THE TREATMENT OF ENDOMETRIOSIS OR LEIOMYOMATATER | |
| MXPA06004547A (en) | Graduated estrogen contraceptive |